openPR Logo
Press release

Pain Management Devices Market 2020 - 2026 Size, Trends, Competitive Analysis, Types, Applications, COVID19 Impact Analysis With Top Manufacturers Analysis | Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific

11-10-2020 05:21 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Pain Management Devices Market

Pain Management Devices Market

Global pain management devices industry accounted for $4.01 billion in 2018, and is anticipated to reach $6.77 billion by 2026, registering a CAGR of 6.7% from 2019 to 2026.

Rise in prevalence of chronic disease, surge in geriatric population, and increase in adoption of pain management devices drive the growth of the global pain management devices market. However, preferable use of medications for pain management hampers the market growth. On the contrary, growth opportunities in emerging markets are expected to create lucrative opportunities in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/169

Based on application, the cancer pain segment is expected to register the fastest CAGR of 8.3% during the forecast period. This is attributed to rise in incidence of different forms of cancer and increase in adoption of cancer pain drugs. In addition, upsurge in geriatric population and wide availability of pain management devices drive the market growth. However, the neuropathic pain segment dominated the global pain management devices market in 2018, accounting for nearly one-third of the market. The increase in number of target population, rise in number of risk factors such as diabetes, HIV, multiple sclerosis, & cancer, technological advancement in pain management devices, and surge in demand for pain management devices for management of neuropathic pain are driving the growth of the segment.

The market across the North America region held the largest share in 2018, accounting for more than two-fifths of the market. The region is expected to maintain its dominance throughout the forecast period, owing to the rise in prevalence of chronic pain, increase in demand for pain management devices, presence of advanced healthcare facilities with trained medical professionals, and higher in number of R&D activities to develop innovative device. On the other hand, the Asia-Pacific region is anticipated to register the fastest CAGR of 8.5% during the forecast period. Improvement in healthcare infrastructure, availability of pain management devices, surge in healthcare reforms, and technological advancements in the field of healthcare are the major factors driving the growth in the region.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/169

Covid-19 scenario:

The demand for Pain Management Devices from the all industry has experienced a huge growth to encourage health and safety with Covid-19 impact.
The supply, demand of Pain Management Devices affected by lockdown as it comes under the category of essential factors.
Based on product, the neuromodulation and neurostimulation devices segment held the largest share in 2018, contributing to more than three-fifths of the global pain management devices market. This is attributed to the rise in adoption of neurostimulation & neuromodulation devices for management of pain due to prevalence of neurological disorders such as Parkinson's disease and migraine. On the other hand, the analgesic infusion pumps segment is expected to register the fastest CAGR of 8.2% during the forecast period, owing to the increase in prevalence of chronic diseases, rise in aging population, technological innovations in analgesic pumps, and surge in adoption of infusion pumps.

Leading market players analyzed in market such as Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp., DJO Global LLC., Johnson & Johnson (Codman And Shurtleff, Inc.,), Kimberly Clark Corporation, Medtronic Plc., Pfizer, Inc., and Stryker Corp.

Read More: https://www.alliedmarketresearch.com/pain-management-devices-market

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, and researchers and students at universities. With reports on more than 60,000 niche markets with data comprising of 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients’ requirements is complemented with analyst support and customization requests.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pain Management Devices Market 2020 - 2026 Size, Trends, Competitive Analysis, Types, Applications, COVID19 Impact Analysis With Top Manufacturers Analysis | Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific here

News-ID: 2184938 • Views:

More Releases from Allied Market Research

Graphene Market Size, Trends, Dynamics, Competitive Scenario and Forecast, 2020 to 2027
Graphene Market Size, Trends, Dynamics, Competitive Scenario and Forecast, 2020 …
The global graphene market generated $87.5 million in 2019, and is expected to reach $876.8 million by 2027, witnessing a CAGR of 40.2% from 2020 to 2027. The report provides a detailed analysis of changing market dynamics, top investment pockets, key segments, competitive landscape, value chain, and regional scenario. Download Sample PDF Brochure: https://www.alliedmarketresearch.com/request-sample/460 According to the report published by Allied Market Research, the Graphene Market by Type (Mono-layer and Bi-layer Graphene, Few
Stucco Market Trends and Opportunities, Grow at a CAGR of 4.5% to 2026
Stucco Market Trends and Opportunities, Grow at a CAGR of 4.5% to 2026
The global stucco market garnered $10.7 billion in 2018 and is anticipated to hit $15.3 billion by 2026, growing at a CAGR of 4.5% from 2019 to 2026. High purchasing power of end-users and development of the global construction industry boosted the growth of the stucco market. On the contrary, low consumer awareness toward the availability of stucco hinders the market. However, increase in demand from emerging economies would open new opportunities
Adhesive Film Market Revenue to Cross USD 26.7 Billion by 2026 | BASF SE, Dymax Corporation, DuPont., Solvay
Adhesive Film Market Revenue to Cross USD 26.7 Billion by 2026 | BASF SE, Dymax …
The global adhesive film industry was estimated at $17.3 billion in 2018, and is expected to hit $26.7 billion by 2026, registering a CAGR of 5.5% from 2019 to 2026. Allied Market Research published a report, titled, "Adhesive Film Market by Film Material (Polypropylene, Polyvinyl Chloride, Polyethylene and Others), Technology (Water-based, Solvent-based, Hot Melt, Pressure-sensitive and Others), and End User Industry (Electrical and Electronics, Aerospace, Automotive and Transportation and Others): Global Opportunity Analysis and Industry Forecast,
Breaking the Shell: The Explosive Growth of the Eggshell Membrane Market, Projected to Reach $8.4+ Billion by 2032
Breaking the Shell: The Explosive Growth of the Eggshell Membrane Market, Projec …
In the intricate web of the global economy, the eggshell membrane market stands out as a rapidly evolving sector. Valued at $3.8 billion in 2022, this niche segment is projected to burgeon to $8.4 billion by 2032, with an impressive compound annual growth rate (CAGR) of 8.9% from 2023 to 2032. The factors driving this growth are multifaceted, spanning from the increased awareness of the membrane's health benefits to strategic

All 5 Releases


More Releases for Pain

Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy. Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023. Global Post-operative Pain Management Market - Overview Post-operative pain management is the most important part
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and